Top Stories
-
Columbia researchers have shined new light on how the “dark” part of the genome allows cancer cells to be detected by the immune system, which could lead to better immunotherapies.
-
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Topic
-
In the past decade, physicians have recommended that women undergoing some surgeries have their fallopian tubes removed at the same time to prevent ovarian cancer.
Topic
-
Columbia expert Dr. Fatemeh Momen-Heravi shares facts about HPV-related cancer risk factors and prevention.
Topic
Latest News
- December 13, 2022
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
Topic
- December 9, 2022
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.
Topic
- November 30, 2022
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
Topic
- November 28, 2022
Bad weather forced the cancellation of the in-person cycling fundraiser, but participants organized their own bike rides and raised $1.1 million for cancer research and patient care at Columbia.
Topic
- November 16, 2022
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.
- November 10, 2022
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
Topic
- November 1, 2022
Columbia's Barbara Pro, MD, widely recognized for her expertise in developing novel drug treatments for lymphoma, shares her insights.
- October 21, 2022
High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
Topic
- October 20, 2022
A new study shows that a shift from quiescent to activated liver cells sets the stage for liver cancer and suggests ways to reduce the risk of developing the cancer in people with liver disease.
Topic
- October 14, 2022
Though women may know they have dense breasts, many don’t know that having dense breasts comes with a slightly elevated risk of developing breast cancer.
Topic
